openPR Logo
Press release

Infectious Disease Point of Care Diagnostics Market to Reach $3371.1 Million by 2027; Increasing R&D Investments and Rising Research Activities have Widened the Application Scope for the Product, says Fortune Business Insights™

08-31-2021 07:57 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Infectious Disease Point of Care Diagnostics Market

Infectious Disease Point of Care Diagnostics Market

Infectious Disease Point of Care Diagnostics Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast latest study published by Fortune Business Insights. The global “infectious disease point of care (PoC) diagnostics market” size is projected to reach USD 3,371.1 million by the end of 2027. The presence of several large-scale companies in this sector will emerge in favor of market growth.

According to a report published by Fortune Business Insights, titled “Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination Test, Flow-through Test, Molecular Diagnostics, and Others), By Disease (HIV, Hepatitis B Virus, Pneumonia/Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV), Influenza, Clostridium Difficile Infections (CDI), Hepatitis C Virus, Methicillin Resistant Staphylococcus Aureus (MRSA), Tuberculosis, and Others), By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home & Self-Testing, Nursing Homes, and Others), and Regional Forecast, 2020-2027” the market was worth USD 1246.5 million and will exhibit a CAGR of 17.4% during the forecast period, 2020-2027.

Point of care (PoC) testing allows faster diagnosis of diseases at the patient site itself. The drawbacks of conventional diagnostic methods including time to test, inefficiency, and non-portability can be overcome through infectious disease PoC diagnosis. Recent technological advances have opened up a massive potential for the growth of the market in the past few years. The increasing popularity of this concept is consequential to the rapid technological advances. The increasing product demand has encouraged companies to invest higher upfront capital. The sector holds a huge potential for entry-level as well as mid-sized companies across the world. Additionally, increasing research activities will also emerge in favor of market growth in the forthcoming years.

Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/sample/infectious-disease-point-of-care-poc-diagnostics-market-104307

This report focuses on Infectious Disease Point of Care Diagnostics Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered complete lockdown of industrial and human activities. This is expected to have a significant impact on the market in 2021. However, proactive steps by the industry leaders to revive the Healthcare industry will bode well for the growth of the market in the near future.

Covid-19 Pandemic to Create Massive Opportunities for Rapid Market Growth
The recent coronavirus outbreak has created a sense of panic and urgency across the world. The pandemic has had a drastic impact on several economies across the globe, with SMEs being affected the most. With only large-scale companies being able to sustain the drawbacks of the pandemic in a seamless manner, it is evident that these companies will look to adopt newer strategies to recover the losses in the past few months. The use of several PoC diagnostic test kits has risen dramatically in the past few months, given the ability of the product to generate results in a time span that is lesser than 30 mins. Having said that, major attention has been given to the SARS-Cov-2 infection and other diagnostic products have been kept on hold. As a result, the Covid-19 pandemic has brought mixed fortunes for companies in the infectious disease PoC diagnostics market.

Increasing Product Use during Covid-19 Pandemic will Emerge in Favor of Market Growth
The report encompasses several factors that have contributed to the growth of the overall market in recent years. The massive investments in infectious disease PoC diagnostics have yielded a few exceptional products, enabling applications across diverse treatment procedures. The product has also been put to use in detecting symptoms of Covid-19 in the ongoing pandemic. Several large-scale companies are looking to maximize the use of the product during the pandemic and as a result, the investments in PoC diagnostics has gone up considerably in the past few months. In May 2020, Quest Diagnostics announced that it has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its self-collection antibody test kits. The product is used for test kit for Covid-19 for patients looking to get tested from home. Increasing number of product innovations will have a huge impact on the growth of the overall market in the coming years.

Quick Buy - Infectious Disease Point of Care Diagnostics Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/104307

North America to Emerge Dominant; Growing Penetration of Advanced PoC Diagnostics will Emerge in Favor of Market Growth
The report analyzes the ongoing market trends across North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing adoption of advanced PoC diagnostics, especially in the United States, has contributed to the growth of the regional market. The increasing Covid-19 cases has also given the platform for companies in the infectious disease PoC diagnostics sector. As of 2019, the market in North America was worth USD 457.2 million and this value is projected to rise at a considerable pace in the coming years. The market in Europe held the second largest share, following North America in the global market.

List of companies profiled in the report:
• F. Hoffmann-La Roche Ltd (Basel, Switzerland)
• Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
• Abbott Laboratories (Illinois, U.S)
• Quest Diagnostics Incorporated (New Jersey, United States)
• BD (Franklin Lakes, U.S)
• bioMérieux SA (Marcy l'Etoile, France)
• Cardinal Health, Inc. (Ohio, U.S)
• Mesa Biotech (California, U.S)
• Cepheid (California, U.S)
• Trinity Biotech (Bray, Ireland)
• Quidel Corporation (San Diego, U.S.)
• Bio-Rad Laboratories Inc. (California, U.S)
• Other Players

Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/infectious-disease-point-of-care-poc-diagnostics-market-104307

Industry Developments:
June 2020 - Cepheid announced launch of Xpert Xpress SARS-CoV-2/Flu/RSV a four in one combination test used for the detection of detection of SARS-CoV-2, Flu A, Flu B and RSV from a sample of single patient.

Global Infectious Disease Point of Care Diagnostics Market Segmentation :

By Technique
• Lateral Flow Immunoassay (LFIA)
• Agglutination Test
• Flow-through test/Immunoconcentration Assay
• Molecular Diagnostics
• Others

By Disease
• HIV
• Hepatitis B Virus
• Pneumonia/Streptococcus Associated Infections
• Respiratory Syncytial Virus (RSV)
• Influenza
• Clostridium Difficile Infections (CDI)
• Hepatitis C Virus
• Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Tuberculosis (TB)
• Others

By End User
• Hospital Bedside
• Physician's Office Lab
• Urgent Care & Retail Clinics
• Home & Self-testing
• Nursing Home
• Others

By Geography
• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Table of Content:

1 Infectious Disease Point of Care Diagnostics Market Overview
1.1 Infectious Disease Point of Care Diagnostics Product Overview
1.2 Infectious Disease Point of Care Diagnostics Market Segment by Type
1.3 Global Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2027)
1.3.1 Global Infectious Disease Point of Care Diagnostics Market Size Overview by Type (2015-2027)
1.3.2 Global Infectious Disease Point of Care Diagnostics Historic Market Size Review by Type (2015-2021)
1.3.2.1 Global Infectious Disease Point of Care Diagnostics Sales Market Share Breakdown by Type (2015-2027)
1.3.2.2 Global Infectious Disease Point of Care Diagnostics Market Share Breakdown by Type (2015-2027)
1.3.2.3 Global Infectious Disease Point of Care Diagnostics Average Selling Price (ASP) by Type (2015-2027)
1.3.3 Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Type (2021-2027)
1.3.3.1 Global Infectious Disease Point of Care Diagnostics Sales Market Share Breakdown by Application (2021-2027)
1.3.3.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share Breakdown by Application (2021-2027)
1.3.3.3 Global Infectious Disease Point of Care Diagnostics Average Selling Price (ASP) by Application (2021-2027)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
1.4.2 Europe Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
1.4.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
1.4.4 Latin America Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
1.4.5 Middle East and Africa Infectious Disease Point of Care Diagnostics Sales Breakdown by Type (2015-2027)
2 Global Infectious Disease Point of Care Diagnostics Market Competition by Company
2.1 Global Top Players by Infectious Disease Point of Care Diagnostics Sales (2015-2021)
2.2 Global Top Players by Infectious Disease Point of Care Diagnostics Revenue (2015-2021)
2.3 Global Top Players Infectious Disease Point of Care Diagnostics Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Infectious Disease Point of Care Diagnostics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Infectious Disease Point of Care Diagnostics Market Competitive Situation and Trends
2.5.1 Infectious Disease Point of Care Diagnostics Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Infectious Disease Point of Care Diagnostics Sales and Revenue in 2019
2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019)
2.7 Date of Key Company Enter into Infectious Disease Point of Care Diagnostics Market
2.8 Key Company Infectious Disease Point of Care Diagnostics Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Infectious Disease Point of Care Diagnostics Status and Outlook by Region (2015-2027)
3.1 Global Infectious Disease Point of Care Diagnostics Market Size and CAGR by Region: 2015 VS 2021 VS 2027
3.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2015-2021)
3.2.1 Global Infectious Disease Point of Care Diagnostics Sales Market Share by Region (2015-2021)
3.2.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2015-2021)
3.2.3 Global Infectious Disease Point of Care Diagnostics Sales, Revenue, Price and Gross Margin (2015-2021)
3.3 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2021-2027)
3.3.1 Global Infectious Disease Point of Care Diagnostics Sales Market Share by Region (2021-2027)
3.3.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2021-2027)
3.3.3 Global Infectious Disease Point of Care Diagnostics Sales, Revenue, Price and Gross Margin (2021-2027)
3.4 North America Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.4.1 North America Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.4.2 North America Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
3.5 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.5.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.5.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
3.6 Europe Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.6.1 Europe Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.6.2 Europe Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
3.7 Latin America Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.7.1 Latin America Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.7.2 Latin America Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
3.8 Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
3.8.1 Middle East and Africa Infectious Disease Point of Care Diagnostics Revenue By Growth (2015-2027)
3.8.2 Middle East and Africa Infectious Disease Point of Care Diagnostics Sales By Growth (2015-2027)
4 Global Infectious Disease Point of Care Diagnostics by Application
4.1 Infectious Disease Point of Care Diagnostics Segment by Application
4.1.1 Residential
4.1.2 Commercial
4.2 Global Infectious Disease Point of Care Diagnostics Sales by Application: 2015 VS 2021 VS 2027
4.3 Global Infectious Disease Point of Care Diagnostics Historic Sales by Application (2015-2021)
4.4 Global Infectious Disease Point of Care Diagnostics Forecasted Sales by Application (2021-2027)
4.5 Key Regions Infectious Disease Point of Care Diagnostics Market Size by Application
4.5.1 North America Infectious Disease Point of Care Diagnostics by Application
4.5.2 Europe Infectious Disease Point of Care Diagnostics by Application
4.5.3 Asia-Pacific Infectious Disease Point of Care Diagnostics by Application
4.5.4 Latin America Infectious Disease Point of Care Diagnostics by Application
4.5.5 Middle East and Africa Infectious Disease Point of Care Diagnostics by Application
5 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2015-2027)
5.1 North America Market Size Market Share by Country (2015-2021)
5.1.1 North America Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2015-2021)
5.1.2 North America Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2015-2021)
5.2 North America Market Size Market Share by Country (2021-2027)
5.2.1 North America Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2021-2027)
5.2.2 North America Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2021-2027)
5.3 North America Market Size By Growth by Country
5.3.1 U.S. Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
5.3.2 Canada Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2015-2027)
6.1 Europe Market Size Market Share by Country (2015-2021)
6.1.1 Europe Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2015-2021)
6.1.2 Europe Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2015-2021)
6.2 Europe Market Size Market Share by Country (2021-2027)
6.2.1 Europe Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2021-2027)
6.2.2 Europe Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2021-2027)
6.3 Europe Market Size By Growth by Country
6.3.1 Germany Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6.3.2 France Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6.3.3 U.K. Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6.3.4 Italy Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
6.3.5 Russia Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Country (2015-2027)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)
7.1.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2015-2021)
7.1.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2015-2021)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)
7.2.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Market Share by Country (2021-2027)
7.2.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2021-2027)
7.3 Asia-Pacific Market Size By Growth by Country
7.3.1 China Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.2 Japan Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.3 South Korea Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.4 India Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.5 Australia Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.6 Taiwan Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.7 Indonesia Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.8 Thailand Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.9 Malaysia Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)
7.3.10 Philippines Infectious Disease Point of Care Diagnostics Market Size By Growth (2015-2027)

Toc Continue…

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Disease Point of Care Diagnostics Market to Reach $3371.1 Million by 2027; Increasing R&D Investments and Rising Research Activities have Widened the Application Scope for the Product, says Fortune Business Insights™ here

News-ID: 2373874 • Views: 278

More Releases from Fortune Business Insights

Immunoglobulin Market to Reach USD 18,378.0 Million by 2025; FDA Approval for AD …
Market Overview: The global immunoglobulin market size is expected to reach USD 18,378.0 million by 2025 exhibiting a CAGR of 7.0% during the forecast period. The increasing diagnosis rates owing to escalating awareness regarding the treatment of immunoglobulins will have a tremendous effect on the market during the forecast period, states Fortune Business Insights in a report, titled “Immunoglobulin Market Size, Share and Industry Analysis By Route of Administration (Intravenous (IV),
Life Science Instrumentation 2021 Global Market Research report covers a detaile …
Global Life Science Instrumentation market2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Life Science Instrumentation Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Life Science Instrumentation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels
Hospital Acquired Infections Treatment 2021 Global Market Research report covers …
Global Hospital Acquired Infections Treatment market2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Hospital Acquired Infections Treatment Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Hospital Acquired Infections Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and
Anti-Inflammatory Biologics Market 2021-2026 Study & Future Prospects Including …
Anti-Inflammatory Biologics Market | 2021 Global Industry Forecast To 2026, is latest report on Global Anti-Inflammatory Biologics Industry, published by Fortune Business Insights. Report provides comprehensive information on Global Anti-Inflammatory Biologics Market and Impact of Covid-19 on Healthcare Industry. According to report Global market value of Anti-Inflammatory Biologics is to hit USD 149.80 billion value by 2027 at CAGR of 11.0%. Report segments Anti-Inflammatory Biologics Market By Drug Class (Anti-Tumor

All 5 Releases


More Releases for Diagnostics

Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Global Influenza Diagnostics Market 2017 : BioMerieux, SA Scientific, Enigma Dia …
Influenza Diagnostics Market 2017 A market study based on the " Influenza Diagnostics Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Influenza Diagnostics Market 2017’. The research report analyses the historical as well as present performance of the worldwide Influenza Diagnostics industry, and makes predictions on the future status of Influenza Diagnostics market on the basis of this analysis. Get Free Sample Copy of
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test